SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a ...

The platform will be showcased at the American Academy of Neurological Surgeons Annual Meeting in Boston on April 25-28, 2025. "The new iCT-guided neuro navigation workflow builds on our team's decade ...

ClearPoint Neuro, Inc. CLPT, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, recently received EU MDR Certification for its ClearPoint ...

SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today ...

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...

ALPHARETTA, GEORGIA, USA, March 28, 2023/EINPresswire.com/ -- MagVenture TMS Atlas™ Neuro Navigation System is a time-saving coil positioning system for the ...

HERSHEY, Pa.--(BUSINESS WIRE)--inTRAvent Medical Partners LP, a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve neurosurgical procedures, ...

SOLANA BEACH, California - ClearPoint Neuro, Inc. (NASDAQ:CLPT), a medical device company with a market capitalization of approximately $597 million and impressive year-to-date returns of 42%, ...

ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has received 510(k ...